Cover & TOC
Document type
monografie, knihy, e-knihy
monografie, knihy, e-knihy
Document record
Source: katalogy Medvik
MARC21 Bibliographic

medvik2
1 _____nam a22002415u 4500
001
krg280561
003
CZ-PrNML
005
20210302094511.0
006
m o d
007
cr unu
008
210217s2020 gw a o 001 0 eng d
009
eBK
020    ##
$a 9783318068344
035    ##
$a (OCoLC)1237600524
040    ##
$a UKSKG $b cze $c UKSKG $b ABA008 $d ABA008
041    0#
$a eng
044    ##
$a gw
100    1#
$a Potluri, Sandeep
245    10
$a Fast Facts: Treatment-Free Remission in Chronic Myeloid Leukemia : $b From concept to practice and beyond / $c Sandeep Potluri
246    00
$a Treatment-Free Remission in Chronic Myeloid Leukemia - From concept to practice and beyond
260    ##
$a Basel : $b S. Karger, $c 2020
300    ##
$a 56 stran : $b ilustrace, tabulky
520    ##
$a The tyrosine kinase inhibitor (TKI) imatinib was the first treatment to specifically target cancer cells, rather than the relatively indiscriminate effects of conventional chemotherapy on any rapidly dividing cells. This concept of targeted treatment in cancer is one of the important advances in modern medicine in the last 30 years. Indeed, treatment with TKIs has transformed chronic myeloid leuke
588    0#
$a Print version record
650    #7
$a hematologie $2 czmesh $7 D006405
650    #7
$a myeloidní leukemie $x terapie $7 D007951 $2 czmesh
650    #7
$a hematologie a transfuzní lékařství $7 nlk20040147649 $2 mednas
650    #7
$a onkologie $7 nlk20040148136 $2 mednas
655    #7
$a příručky $7 D020479 $2 czmesh
776    08
$i Print version: $t Fast Facts: Treatment-Free Remission in Chronic Myeloid Leukemia $z 9783318068337
856    40
$u https://www.medvik.cz/link/access.do?source=portal&url=https://www.karger.com/Book/Home/280561 $y plný text - pouze pro uživatele NLK $z Karger Fast Facts e-book
910    ##
$a ABA008 $b ebook $t l $y x
974    ##
$f El. knihy / e-books
999    ##
$a ok
Clipboard
Further actions